Masayuki Okuno

5PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 01, 2026
Treatment Interval as a Prognostic Marker in Patients Undergoing Repeated Curative-Intent Local Treatment for Recurrent Hepatocellular Carcinoma.

|Nov 07, 2025
Clarifying Treatment Compliance and Future Directions in Perioperative Chemotherapy for Resectable Colorectal Liver Metastases.

Masayuki Okuno, Hiroto Nishino, Takamichi Ishii

|Sep 27, 2024
A classification model for resectability in hepatocellular carcinoma patients.

Ikuo Nakamura, Tomoaki Yoh, Takashi Nishimura

|Jul 04, 2024
A patient who underwent conversion surgery after atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein thrombosis and perihepatic lymph node metastases achieved a pathological complete response.

Masayuki Okuno, Hideko Ohama, Ikuo Nakamura

|May 04, 2020
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.

Masayuki Okuno, Etsuro Hatano, Rei Toda

Pageof 1

Frequent Collaborators

3 joint publications

Etsuro Hatano

2 joint publications

Takamichi Ishii

1 joint publications

Satoru Seo

1 joint publications

Tomoaki Yoh